山东大学教师主页黄伯世 Paper Publications Home

CBc og5 xqR rAv omW KaV tBZ TWF u0O c7y CTE un1 Shu 6tn dno wjZ 4M7 7Je jDu 9w7

Huang Boshi

Doctor

Postgraduate (Postdoctoral)

山东大学

Recommended Ph.D.Supervisor

Recommended MA Supervisor

Personal Information

Gender:Male
Date of Employment:2022-10-14
Business Address:1. 济南市山大南路27号山东大学中心校区明德楼B237
2. 济南市山东大学国家大学科技园（二环南路与兴仲路交汇处）3号楼

Home > Scientific Research > Paper Publications

[1] . Discovery of novel fused-heterocycle-bearing diarypyrimidine derivatives as HIV-1 potent NNRTIs targeting tolerant region I for enhanced antiviral activity and resistance profile. EUROPEAN JOURNAL OF MEDICINAL CHEMIST..., 2024.
[2] 代娇娇. Discovery of novel fused-heterocycle-bearing diarypyrimidine derivatives as HIV-1 potent NNRTIs targeting tolerant region I for enhanced antiviral activity and resistance profile. EUROPEAN JOURNAL OF MEDICINAL CHEMIST..., 281, 2025.
[3] 黄伯世. Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies. Journal of Medicianal Chemistry, 64, 13604-13621, 2021.
[4] 黄伯世. First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain. BIOORGANIC & MEDICINAL CHEMISTRY LETT..., 28, 1348, 2018.
[5] Design of bivalent ligands targeting putative GPCR dimers. Drug Discovery Today, 26, 189-199, 2021.
[6] Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives. Drug Discovery Today, 27, 1936-1944, 2022.
[7] Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mu.... Journal of Medicinal Chemistry, 62, 2083–2098, 2019.
[8] Structure-based Design and Discovery of Pyridyl-bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies. Journal of Medicinal Chemistry, 64, 13604–13621, 2021.
[9] Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity. Journal of Medicinal Chemistry, 64, 7702–7723, 2021.
[10] Rational Design, Chemical Syntheses, and Biological Evaluations of Peripherally Selective Mu Opioid Receptor Ligands as Potential Opioid Induced Constipation Treatment. Journal of Medicinal Chemistry, 65, 4991-5003, 2022.

TOTAL 10 PIECE 1/1

FIRSTPREVIOUSNEXTLAST

Home

Scientific Research

Teaching Research

Awards and Honours

Enrollment Information

Student Information

My Album

Blog

Recommended Ph.D.Supervisor

Recommended MA Supervisor

Personal Information